Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival
Top Cited Papers
Open Access
- 1 June 2007
- journal article
- Published by American Society of Hematology in Blood
- Vol. 109 (11), 4599-4606
- https://doi.org/10.1182/blood-2006-08-039859
Abstract
A gene expression signature of tumor proliferation rate in mantle cell lymphoma (MCL) is an overriding molecular predictor of the length of survivalKeywords
This publication has 49 references indexed in Scilit:
- Cyclin D1: polymorphism, aberrant splicing and cancer riskOncogene, 2006
- The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and EvolutionScience, 2005
- Phase II Trial of Single-Agent Temsirolimus (CCI-779) for Relapsed Mantle Cell LymphomaJournal of Clinical Oncology, 2005
- Combinatorial microRNA target predictionsNature Genetics, 2005
- Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammalsNature, 2005
- Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAsNature, 2005
- A small deletion in the 3′-untranslated region of the cyclin D1/PRAD1/bcl-1 oncogene in a patient with chronic lymphocytic leukemiaInternational Journal of Cancer, 1998
- Cyclin D1 (PRAD1) alternative transcript b: full-length cDNA cloning and expression in breast cancersCancer Letters, 1997
- Absence of cyclin D1/PRAD1 point mutations in human breast cancers and parathyroid adenomas and identification of a new cyclin D1 gene polymorphismCancer Letters, 1995
- Cyclosporin A inhibits growth of autocrine tumour cell lines by destabilizing interleukin-3 mRNANature, 1994